166 related articles for article (PubMed ID: 28635398)
1. GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma.
Liu T; Kan XF; Ma C; Chen LL; Cheng TT; Zou ZW; Li Y; Cao FJ; Zhang WJ; Yao J; Li PD
Tumour Biol; 2017 Jun; 39(6):1010428317700410. PubMed ID: 28635398
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma.
Wang JH; Wei W; Xu J; Guo ZX; Xiao CZ; Zhang YF; Jian PE; Wu XL; Shi M; Guo RP
Oncotarget; 2015 Oct; 6(33):35116-28. PubMed ID: 26375669
[TBL] [Abstract][Full Text] [Related]
4. Expression of Fra-1 in human hepatocellular carcinoma and its prognostic significance.
Gao XQ; Ge YS; Shu QH; Ma HX
Tumour Biol; 2017 Jun; 39(6):1010428317709635. PubMed ID: 28653890
[TBL] [Abstract][Full Text] [Related]
5. Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma.
Wang JH; Wei W; Guo ZX; Shi M; Guo RP
J Transl Med; 2015 Feb; 13():41. PubMed ID: 25638165
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma.
Huang LL; Zhang Y; Zhang JX; He LJ; Lai YR; Liao YJ; Tian XP; Deng HX; Liang YJ; Kung HF; Xie D; Zhu SL
Tumour Biol; 2015 Jun; 36(6):4405-15. PubMed ID: 25596704
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
9. High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes.
Pu M; Wang J; Huang Q; Zhao G; Xia C; Shang R; Zhang Z; Bian Z; Yang X; Tao K
Tumour Biol; 2017 Jul; 39(7):1010428317709127. PubMed ID: 28714366
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic function and prognostic significance of Abelson interactor 1 in hepatocellular carcinoma.
Wang JL; Yan TT; Long C; Cai WW
Int J Oncol; 2017 May; 50(5):1889-1898. PubMed ID: 28339046
[TBL] [Abstract][Full Text] [Related]
11. Loss of function of Notch1 identifies a poor prognosis group of early stage hepatocellular carcinoma following hepatectomy.
Liu J; Liu JF; Wang K; Yan ZL; Wan XY; Huang AM; Wang YZ; Li J; Xia Y; Shi LH; Jiao BH; Zhang Y; Shen F
Oncol Rep; 2015 Dec; 34(6):3174-86. PubMed ID: 26398566
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of purinergic P2X7 receptor expression in patients with hepatocellular carcinoma after curative resection.
Liu H; Liu W; Liu Z; Liu Y; Zhang W; Xu L; Xu J
Tumour Biol; 2015 Jul; 36(7):5039-49. PubMed ID: 25722111
[TBL] [Abstract][Full Text] [Related]
13. The overexpression and prognostic role of DCAF13 in hepatocellular carcinoma.
Cao J; Hou P; Chen J; Wang P; Wang W; Liu W; Liu C; He X
Tumour Biol; 2017 Jun; 39(6):1010428317705753. PubMed ID: 28631558
[TBL] [Abstract][Full Text] [Related]
14. DEP domain containing 1 is a novel diagnostic marker and prognostic predictor for hepatocellular carcinoma.
Yuan SG; Liao WJ; Yang JJ; Huang GJ; Huang ZQ
Asian Pac J Cancer Prev; 2014; 15(24):10917-22. PubMed ID: 25605201
[TBL] [Abstract][Full Text] [Related]
15. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
[TBL] [Abstract][Full Text] [Related]
16. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M
Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035
[TBL] [Abstract][Full Text] [Related]
17. Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma.
Chen J; Li S; Zhou S; Cao S; Lou Y; Shen H; Yin J; Li G
J Cancer Res Ther; 2017; 13(4):651-659. PubMed ID: 28901309
[TBL] [Abstract][Full Text] [Related]
18. GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
Chang IW; Lin VC; Hung CH; Wang HP; Lin YY; Wu WJ; Huang CN; Li CC; Li WM; Wu JY; Li CF
World J Urol; 2015 Nov; 33(11):1777-89. PubMed ID: 25813210
[TBL] [Abstract][Full Text] [Related]
19. High expression of IL-9R promotes the progression of human hepatocellular carcinoma and indicates a poor clinical outcome.
Li HJ; Sun QM; Liu LZ; Zhang J; Huang J; Wang CH; Ding R; Song K; Tong Z
Oncol Rep; 2015 Aug; 34(2):795-802. PubMed ID: 26082242
[TBL] [Abstract][Full Text] [Related]
20. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]